Human Investing’s Evolus EOLS Stock Holding History

Human Investing’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300	Closed	-$5K	–	364
2019 Q3	$5K	Hold	300	–	–	﹤0.01%	305
2019 Q2	$4K	Hold	300	–	–	﹤0.01%	306
2019 Q1	$7K	Buy	+300	New	+$6.49K	﹤0.01%	274

Other funds holding EOLS

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

Human Investing's EOLS Position: Q4 2019 in Review

Human Investing sold out of Evolus (EOLS) in Q4 2019, closing a stake of 300 shares — an estimated $5K sold.

Human Investing first reported a position in EOLS in Q1 2019 and held it in 3 quarters. The position peaked at $7K in Q1 2019. 106 funds tracked by Wall St. Rank hold EOLS as of Q4 2019.

Human Investing reported no remaining Evolus position as of Q4 2019 after selling out during the quarter.
Human Investing sold 300 Evolus shares in Q4 2019, an estimated $5K.
Human Investing first reported a position in Evolus in Q1 2019 and held it in 3 quarters.
Human Investing's Evolus position peaked at $7K in Q1 2019.
106 funds tracked by Wall St. Rank held Evolus as of Q4 2019.

Based on Human Investing's 13F filing for Q4 2019, filed 7 Feb 2020.